These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35321956)

  • 1. Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
    Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
    Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.
    Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK;
    Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.
    Hwang SW; Kim JH; Im JP; Ye BD; Koo HS; Huh KC; Cheon JH; Kim YS; Kim YH; Han DS; Kim WH; Kim JS;
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1716-1722. PubMed ID: 28251684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study.
    Kim B; Cheon JH; Moon HJ; Park YR; Ye BD; Yang SK; Seo GS; Jang BI; Kim YS; Kim JS; Han DS; Kim YH; Kim WH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):126-32. PubMed ID: 26406334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.
    Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
    Kim HJ; Oh SH; Lee SH; Kim YB; Kim DY; Park SH; Ye BD; Yang SK; Kim KM
    Gut Liver; 2021 Nov; 15(6):851-857. PubMed ID: 33833134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Korean Patients with Elderly-Onset Crohn's Disease: Results from the Prospective CONNECT Study.
    Kim YS; Na MJ; Ye BD; Cheon JH; Im JP; Kim JS;
    Gut Liver; 2022 Nov; 16(6):995-1000. PubMed ID: 36379905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
    Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
    Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.
    Qiu Y; Chen BL; Feng R; Zhang SH; He Y; Zeng ZR; Ben-Horin S; Peyrin-Biroulet L; Mao R; Chen MH
    J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and long-term prognosis of Crohn's disease in Korea.
    Ye BD; Yang SK; Cho YK; Park SH; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Kim JH
    Scand J Gastroenterol; 2010 Oct; 45(10):1178-85. PubMed ID: 20560811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
    BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis?
    Coelho R; Magro F; Silva M; Macedo G
    Scand J Gastroenterol; 2016; 51(6):679-83. PubMed ID: 26679346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study.
    Wan J; Wang X; Zhang Y; Xue X; Li Y; Liu Z; Han S; Chen M; Nie Y; Shi Y; Liang J; Wu K
    Can J Gastroenterol Hepatol; 2021; 2021():1412663. PubMed ID: 34422708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
    Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.
    Lovasz BD; Lakatos L; Horvath A; Szita I; Pandur T; Mandel M; Vegh Z; Golovics PA; Mester G; Balogh M; Molnar C; Komaromi E; Kiss LS; Lakatos PL
    World J Gastroenterol; 2013; 19(14):2217-26. PubMed ID: 23599648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.